Sunday, 15 September 2013

Biosensors Market Will Reach USD 18.9 Billion Globally in 2018 : Transparency Market Research

According to a new market report published by Transparency Market Research “Biosensors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018,” in 2011, the global biosensors market was valued at USD 9.9 billion and it is expected to grow at a CAGR of 9.6% from 2012 to 2018 to reach a market of USD 18.9 billion by 2018.
A biosensor is made up of two elements: a biological recognition unit which has the ability to interact specifically with a target, and a transducer which is able to change the property of the solution or surface, due to formation, into a recordable signal. This recordable signal can then be analyzed for a variety of applications including but not limited to immunology, detection of specific compounds or specific biological organisms. The key applications for biosensors are found in healthcare, industrial process control and biodefense. New applications are also being discovered as biosensors become smaller, more user-friendly and are able to detect multiple targets.
Since healthcare, more specifically blood glucose testing for diabetics, forms the largest market for biosensors, it is critical for the growth of this segment. The unprecedented growth in the world’ saging population has led to a rise in the incidence of chronic diseases such as diabetes, cardiovascular diseases and cancer. According to the World Diabetes Foundation, it is estimated that approximately 285 million people accounting for 6.4% of the world’s adult population live with diabetes and the number is expected to grow to 438 million by 2030 corresponding to 7.8% of the adult population. This increase in the aging population, coupled with a rise in the incidence of diabetes, is expected to propel the growth of this market. Blood glucose testing sensors account for the largest share of the global biosensors market and the market for this application was valued at USD 4.7 billion in 2011 and is expected to grow at a CAGR of 10.7% from 2012 to 2018.

Although electrochemical biosensors currently account for the largest market by technology, the market for optical biosensors is the fastest growing segment and is expected to grow at a CAGR of over 10% from 2012 to 2018. The use of biosensors for non-medical applications is on a rise, and the ever increasing defense expenditures will ensure that the bio-defense application of biosensors would have the highest growth in the forecast period.
Geographically, North America constituted the largest market in the year 2011; however, the Asian region is anticipated to grow at the highest CAGR of more than 11% from 2012 to 2018. This is mainly due to the rise in diabetic population, rise in disposable incomes of citizens (thereby leading to a rise in the incidence of lifestyle-related diseases) and increasing awareness about new technologies for disease detection in the region. Favorable reimbursement policies and “research funding” by governments in the region will also provide the required impetus for the growth of the biosensors market.
The global biosensors market is predominantly oligopolistic and ruled by eminent players namely, Roche Diagnostics, Abbott Diagnostics, Bayer Diagnostics and others.
The global biosensors market has been segmented as follows:
Biosensors Market, by Technology
  • Electrochemical
  • Optical
  • Piezoelectric
  • Thermistors
Biosensors Market, by Applications
  • Medical Applications
    • Blood glucose testing
    • Blood gas analyzers
    • Cholesterol testing
    • Infectious diseases
    • Pregnancy testing
    • Others
  • Food Toxicity detection
  • Environmental
  • Industrial
  • Agricultural
  • Others
Biosensors Market, By End-users
  • Home diagnostics
  • Point of care testing
  • Research laboratories
  • Security & Bio-defense
  • Others
Biosensors Market, by Geography
  • North America
  • Europe
  • Asia
  • Rest of the World (RoW)
About Us:
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact: 
Transparency Market Research

90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Saturday, 14 September 2013

Glycolic Acid Market Will Reach USD 203.3 million By 2018 : Transparency Market Research

Transparency Market Research published new market report “Glycolic Acid Market for Personal Care, Household Cleaning, Industrial and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018,” the global demand for glycolic acid was valued at USD 93.30 million in 2011 and is expected to reach USD 203.34 million in 2018, growing at a CAGR of 11.8% from 2012 to 2018. In terms of volume, the demand was 40.0 kilo tons in 2011 and is expected to reach 78.1 kilo tons in 2018, growing at a CAGR of 10.1% from 2012 to 2018.
Glycolic acid is extensively used in a wide range of personal care products such as face lotions, moisturizers and face peels. Rising consumer awareness regarding healthy skin and hair is expected to boost the demand for glycolic acid based skincare and haircare products. Furthermore, growing use of glycolic acid in the manufacturing of polyglycolic acid (PGA), which is used in absorbable medical sutures, is expected to fuel the growth of the market over the next few years. However, inhibitions regarding the hazardous nature of concentrated glycolic acid coupled with the growth of alternate products such as salicylic are expected to hamper the growth of the market.
Personal care products were the largest application segment for glycolic acid and accounted for over 55% of the demand in 2011. This segment is expected to be the fastest growing due to the rising demand for skincare and haircare products. In addition, rising ageing population in countries such as the U.S. and Japan and the consequent demand for anti-ageing creams is expected to drive the demand for glycolic acid. Household cleaning is expected to be the second fastest application segment for glycolic acid, growing at a CAGR of over 9% from 2012 to 2018.

North America was the largest consumer of glycolic acid accounting for over 14,000 tons of global consumption in 2011. Europe and Asia Pacific together accounted for over 50% of consumption in 2011 primarily due to the growing personal care market in countries such as Russia, Poland, India, China and France. Asia Pacific is expected to be the fastest growing market over the forecast period and is expected to grow at a CAGR of 10.5% from 2012 to 2018. Brazil and Middle East are expected to drive the demand in Rest of the World.
Some of the key participants profiled in the report include DuPont, Parchem, Phibro Animal Health Corporation and Sigma-Aldrich among others. The report gives a detailed market share analysis of these companies.
The report gives a comprehensive view of the glycolic acid market in terms of volume and revenue. In addition, the report includes current demand analysis and forecast for each application in North America, Europe, Asia Pacific and Rest of the World. The report comprises of the following segments:
Glycolic Acid Market: Application Analysis
  • Personal Care
  • Household Cleaning
  • Industrial
  • Others (Sutures, PGA)
The report provides a cross-sectional analysis of all the above application segments with respect to the following regions:
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)
In addition, the study provides volumes and revenue for the glycolic acid market in key European countries such as:
  • Germany
  • Spain
  • Italy
  • France
  • United Kingdom
  • Netherlands
  • Russia
  • Ukraine
  • Poland
  • Others
About Us:
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research

90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Friday, 13 September 2013

Liquefied Petroleum Gas Market (LPG) Will Reach USD 266.41 Billion in 2018 : Transparency Market Research

Transparency Market Research published new market report “Liquefied Petroleum Gas (LPG) Market (Refinery, Associated Gas and Non-Associated Gas) for Residential/Commercial, Chemical, Industrial, Auto Fuel, Refineries and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018“, the global LPG market was valued at USD 210.07 billion in 2011 and is expected to reach USD 266.41 billion by 2018, growing at a CAGR of 4.0% over the forecast period from 2012 to 2018. In terms of volume, LPG demand was 252.50 million tons in 2011 and is expected to reach 327.19 million tons by 2018, growing at a CAGR of 3.8% over the forecast period from 2012 to 2018.
Owing to cost benefits offered by LPG over other conventional fuels such as gasoline and diesel, has resulted in enhanced demand for autogas vehicles, further leading to increase in LPG consumption on a global scale. Environmental benefits of LPG, such as low carbon emissions and cost and operational benefits, is expected to drive market demand over the forecast period. However, fluctuations in crude oil prices and downstream derivatives, coupled with high transportation costs is expected to hinder LPG market growth.
Refineries were the largest source of LPG, accounting for over 45% of total demand in 2011. LPG source varies with region, as demand for LPG in North America is met mainly from natural gas whereas; Asia Pacific is primarily dependent on refineries for LPG production. The global demand for LPG derived from associated gas is expected to reach 83.28 million tons by 2018. Increasing development in Natural Gas Liquids (NGL) production in North America is expected to boost the LPG market.

Residential/commercial sector dominated the LPG market and accounted for 47% of total consumption in 2011. Growing use of LPG as a fuel in cooking and space heating is expected to drive the market over the next five years. It is also expected to be the fastest growing segment at a CAGR of 4.5% from 2012 to 2018. Auto fuel segment is expected to show significant growth at an estimated CAGR of 4.4% from 2012 to 2018. Growth in auto gas demand in countries such as Turkey, South Korea and Poland are expected to contribute to its global demand. Petrochemical industry is expected to continue absorbing the price sensitive demand of LPG in the near future, owing to rapid petrochemicals capacity addition mainly in Middle East and Asia Pacific.
Asia Pacific emerged as the leading consumer of LPG and accounted for 35% of the global demand in 2011. Asia Pacific is also expected to be the fastest growing market at an estimated CAGR of 4.8% from 2012 to 2018. The growing consumption of LPG (autogas) as an automobile fuel in Thailand, South Korea, Japan and Australia is also expected to boost its demand over the forecast period. North America and Europe together accounted for 38.9% of the global market in 2011.
The global LPG market is highly fragmented and includes numerous companies almost having equal market share. However, in terms of numbers, top four companies in the market accounted for 18.1 % of the global production in 2012. British Petroleum Plc, Chevron Corporation, China National Petroleum Corporation, Exxon Mobil Corporation and Phillips 66 are key players among others.
The report segments the global LPG market as,
LPG Market: Source Analysis,
  • Refineries
  • Associated gas
  • Non-associated gas
LPG Market: Application Analysis,
  • Residential/commercial
  • Chemical
  • Industrial
  • Auto fuel
  • Refineries
  • Other (including agriculture, refrigerant, aerosol, etc.)
LPG Market: Regional Analysis,
  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America
About Us:
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research

90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Thursday, 12 September 2013

Artificial Vital Organs and Medical Bionics Market Will Reach USD 32.3 Billion Globally in 2018 : Transparency Market Research

According to a new market research report published by Transparency Market Research “Artificial Vital Organs and Medical Bionics Market(Artificial Heart, Kidney, Liver, Pancreas & Lungs, Ear Bionics, Vision Bionics, Exoskeletons, Bionic Limbs, Brain Bionics and Cardiac Bionics)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018,“ in 2011, the artificial vital organs and medical bionics market was valued at USD 17.5 billion and it is expected to grow at a CAGR of 9.2% from 2012 to 2018, to reach an estimated value of USD 32.3 billion in 2018.
An artificial organ is a man-made device, which is integrated or implanted into the patient, to replace an original diseased organ and restore its specific function. Medical bionics is the study of application of mechanics and electronics to replace a limb or other part of a functional organ that is mechanically powered. With rapid development in healthcare technology, organ transplantation has evolved as a common surgical practice. With years of extensive research and development in the field of medical devices and related technological innovations, artificial vital organs and medical bionics are successfully established as viable alternatives for the replacement of donor organs as the latter are not able to keep pace with an increase in demand for efficient rehabilitation of the physically challenged.
The global artificial vital organs market is segmented into artificial heart, kidney, lungs, liver and pancreas markets. The market for artificial vital organs is led by the artificial kidney segment, in terms of revenue. Increase in prevalence of renal disorders and acute renal failure due to the sedentary lifestyle is a major driver for this market. Increase in the prevalence of cardiovascular diseases leading to acute cardiac failure has led to a growing need for heart replacement. Also, the number of patients awaiting transplant are far more than the availability of donor organs and this has led to an increase in the demand for total artificial heart (TAH). The market for total artificial heart is expected to grow at a CAGR of more than 9% from 2012 to 2018.

The medical bionics market is categorized into ear bionics (cochlear implants), vision bionics, exoskeletons, bionic limbs, brain bionics and cardiac bionics. High prevalence of occupation and age-related disabilities demands novel methods of patient rehabilitation to offer a better life for such patients. The market for exoskeletons is expected to emerge as the fastest growing segment, at a CAGR of over 15% from 2012 to 2018.
Geographically, North America leads the market for artificial vital organs and medical bionics. Aging of the baby boomer population and the corresponding rise in prevalence of acute cases of cardiovascular diseases, renal diseases and respiratory disorders, and the increase in prevalence of age-related disorders and occupation-related disabilities are the major drivers for the growth in demand for artificial organs in North America. However, improvement in healthcare expenditure and healthcare infrastructure and rising scope of medical tourism will increase the market share of Asia-Pacific in the future.
The key players in the artificial vital organs and medical bionics market include Abbott Diabetes Care, Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Baxter International, Inc., Gambro AB, Medtronic, Inc., Nikkiso Co., Ltd., SynCardia Systems, Inc., Ossur Hf, WorldHeart Corporation, Ekso Bionics, Touch Bionics, Ottobock Healthcare Gmbh, Second Sight Medical Products, Inc. and others.
The global artificial vital organs and medical bionics market is segmented as follows:
Artificial Vital Organs and Medical Bionics Market, by Product Types
  • Artificial Vital Organs Market
    • Artificial Heart
      • Total Artificial Heart
    • Artificial Kidney
      • Hemodialysis Machines
    • Artificial Liver
    • Artificial Pancreas
      • Insulin Pumps
    • Artificial Lungs
      • Heart-Lung Bypass Machine
      • Oxygenators
  • Medical Bionics Market
    • Ear Bionics (Cochlear implants)
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
      • Bionic Leg
      • Bionic Hand
    • Brain Bionics
      • Spinal Cord Stimulators
      • Deep Brain Stimulators
      • Vagus Nerve Stimulators
    • Cardiac Bionics
      • Ventricular Assist Devices (VAD)
        • Left Ventricular Assist Device (LVAD)
        • Right Ventricular Assist Device (RVAD)
      • Heart Valves
        • Mechanical Heart Valves
        • Biological Tissue Valves
        • Transcatheter Heart Valves
Artificial Vital Organs and Medical Bionics Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Visit: http://www.transparencymarketresearch.com/

Epigenetics Drugs and Diagnostic Technologies Market Will Reach USD 5.7 Billion Globally in 2018 : Transparency Market Research

According to a new market report published by Transparency Market Research  “Epigenetics Drugs and Diagnostic Technologies Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018,” the global epigenetic drugs and diagnostic technologies market was valued at USD 1.6 billion in 2011 and is estimated to reach a market worth USD 5.7 billion in 2018 at a CAGR of 19.4% from 2012 to 2018.
The growth of the epigenetics market is driven by factors such as increase in aging population, as there is a strong correlation between cancer and aging. According to WHO, it is estimated that global population over the age of 60 years would double from 11% (2000) to 22% (2050). People aged 60 and above are more prone to cancer. Hence, countries are advocating early detection of cancer through screening kits (Epi Procolon, Epi ProLung) which are driving the epigenetic drugs and diagnostic technologies market.
Epigenetic drugs make it possible to reverse the aberrant gene expression which leads to various disease states. The inhibitors, DNA methyltransferase (DNMT) and Histone Deacetylase (HDAC) are responsible for regulating the cellular expression. Out of the two inhibitors, DNMT accounts for a larger share as these inhibitors offer an improved access for targeting the cancerous cells. Currently, four drugs are approved by FDA and are commercially available. Two of them are DNMT inhibitors: Celgene’s Vidaza (azacitidine) and Eisai’s Dacogen (decitabine) for the treatment of Myelodysplastic Syndrome (MDS), and the other two are HDAC inhibitors: Merck’s Zolinza (vorinostat) and Celgene’s Istodax (romidepsin) both for treatment of Cutaneous T Cell Lymphoma (CTCL).

Epigenetics is a rapidly developing field not only in oncology but also in non-oncology indications (Alzheimer’s and arthritis). Due to the increase in disease identification, manufacturers are taking initiatives in development of varied epigenetic diagnostic techniques. DNA methylation technique in the diagnostic segment accounts for the largest share as compared to histone modification techniques, as the research on DNA methylation has been carried out since decades, and is thus mostly preferred. Furthermore, with the corresponding advancements in research and technology, histone code hypothesis technique came into existence only in late 1980s. Hence, with the surge in interest, there is also an increase in investment for the research and development of histone modifications.
North America accounts for the largest share of the epigenetics market. It is expected that North America will dominate around half of the global epigenetics market due to increasing incidence of cancer and other non-oncology indications. Oncology and other non-oncology indications (Alzheimer’s and arthritis) are associated with epigenetics; thus the increasing incidence of cancer supports the growth of the epigenetics market. Asia accounts for nearly half of the new cancer cases worldwide.
The rising incidence of cancer cases in the Asian region would boost the demand for epigenetic drugs and diagnostic technologies in this market. Australia, China, Japan and South Korea are the largest markets for these therapies. Japan dominates the epigenetics market in Asia-Pacific due to a significant presence of companies in the therapeutics segment such as Eisai Pharmaceuticals and Oncolys Biopharma. These companies are taking initiatives for the development and commercialization of epigenetic drugs. Various research institutes and investments from these companies would drive the epigenetics market.
Some of the key players in this market include Celgene Corporation, Merck, Eisai Pharmaceuticals, Exact Sciences, Epigenomics and others. Manufacturers are entering into strategic alliances with numerous research institutions and other players for the development and commercialization of new and innovative drugs, which might see new players in the market looking to carve out a share of the market for themselves.
The epigenetics drugs and diagnostic technologies market is segmented as follows:
Epigenetics Drugs Market, by Mechanism
DNMT Inhibitors,HDAC Inhibitors
Epigenetics Diagnostic Technologies Market, by Types
DNA Methylation ,Chromatin Immunoprecipitation (ChIP) Technology
Epigenetics Technologies Market, by Geography
North America,Europe ,Asia-Pacific,RoW
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Visit: http://www.transparencymarketresearch.com/